SAI MedPartners Acquires IDEA Pharma
November 14, 2024
SAI MedPartners, a global life-sciences consultancy backed by Northlane Capital Partners, has acquired London-headquartered IDEA Pharma to strengthen its pharmaceutical path-to-market, clinical development, and commercialization capabilities. The acquisition is an add-on to SAI's platform, expanding its strategic services offering to biopharma and medical device clients.
- Targets
- IDEA Pharma
- Platforms
- SAI MedPartners
- Industry
- Healthcare Services
- Location
- United Kingdom
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.